Lithuania distinguishes cannabis and industrial hemp by the THC concentration of 0.2%. CBD extracts, full spectrum and finished products are not allowed on the market, but bill XIIIP-3195 (2) could legalise these products. This report offers a detailed analysis of the current regulatory framework in Lithuania and also discusses possible future regulation and how it might affect the current regime. The report covers all aspects of law including extracts, finished products, import and export rules, and medical and recreational cannabis.